Inflammatory Activity on Natalizumab Predicts Short-Term but Not Long-Term Disability in Multiple Sclerosis

BACKGROUND: In people with multiple sclerosis treated with interferon-beta or glatiramer acetate, new MRI lesions and relapses during the first year of treatment predict a poor prognosis. OBJECTIVE: To study this association in those receiving natalizumab. METHODS: Data were collected on relapses, n...

Descripción completa

Detalles Bibliográficos
Autores principales: Raffel, Joel, Gafson, Arie R., Dahdaleh, Samer, Malik, Omar, Jones, Brynmor, Nicholas, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5231343/
https://www.ncbi.nlm.nih.gov/pubmed/28081190
http://dx.doi.org/10.1371/journal.pone.0169546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5231343/
https://www.ncbi.nlm.nih.gov/pubmed/28081190
http://dx.doi.org/10.1371/journal.pone.0169546

Ejemplares similares